Trial · NCT04437511
Results by group33
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 33
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline on the Integrated Alzheimer's Disease Rating Scale (iADRS) (Overall Population) | Donanemab | -10.19 | Standard Error 0.53 | score on a scale | |
| Change From Baseline on the Integrated Alzheimer's Disease Rating Scale (iADRS) (Overall Population) | Placebo | -13.11 | Standard Error 0.50 | score on a scale | |
| Change From Baseline on the Integrated Alzheimer's Disease Rating Scale (iADRS) (Intermediate (Low-medium) Tau Population) | Donanemab | -6.02 | Standard Error 0.50 | score on a scale | |
| Change From Baseline on the Integrated Alzheimer's Disease Rating Scale (iADRS) (Intermediate (Low-medium) Tau Population) | Placebo | -9.27 | Standard Error 0.49 | score on a scale | |
| Change From Baseline on the Mini Mental State Examination (MMSE) Score (Overall Population) | Donanemab | -2.47 | Standard Error 0.14 | score on a scale | |
| Change From Baseline on the Mini Mental State Examination (MMSE) Score (Overall Population) | Placebo | -2.94 | Standard Error 0.13 | score on a scale | |
| Change From Baseline on the Mini Mental State Examination (MMSE) Score (Intermediate (Low-medium) Tau Population) | Donanemab | -1.61 | Standard Error 0.14 | score on a scale | |
| Change From Baseline on the Mini Mental State Examination (MMSE) Score (Intermediate (Low-medium) Tau Population) | Placebo | -2.09 | Standard Error 0.14 | score on a scale | |
| Change From Baseline on the Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog13) (Overall Population) | Donanemab | 5.46 | Standard Error 0.28 | score on a scale | |
| Change From Baseline on the Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog13) (Overall Population) | Placebo | 6.79 | Standard Error 0.27 | score on a scale | |
| Change From Baseline on the Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog13) (Intermediate (Low-medium) Tau Population) | Donanemab | 3.17 | Standard Error 0.27 | score on a scale | |
| Change From Baseline on the Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog13) (Intermediate (Low-medium) Tau Population) | Placebo | 4.69 | Standard Error 0.26 | score on a scale | |
| Change From Baseline on the Clinical Dementia Rating Scale-Sum of Boxes (CDR-SB) (Overall Population) | Donanemab | 1.72 | Standard Error 0.096 | score on a scale | |
| Change From Baseline on the Clinical Dementia Rating Scale-Sum of Boxes (CDR-SB) (Overall Population) | Placebo | 2.42 | Standard Error 0.092 | score on a scale | |
| Change From Baseline on the Clinical Dementia Rating Scale-Sum of Boxes (CDR-SB) (Intermediate (Low-medium) Tau Population) | Donanemab | 1.20 | Standard Error 0.105 | score on a scale | |
| Change From Baseline on the Clinical Dementia Rating Scale-Sum of Boxes (CDR-SB) (Intermediate (Low-medium) Tau Population) | Placebo | 1.88 | Standard Error 0.102 | score on a scale | |
| Change From Baseline on the Alzheimer's Disease Cooperative Study - Instrumental Activities of Daily Living (ADCS-iADL) Score (Overall Population) | Donanemab | -4.42 | Standard Error 0.32 | score on a scale | |
| Change From Baseline on the Alzheimer's Disease Cooperative Study - Instrumental Activities of Daily Living (ADCS-iADL) Score (Overall Population) | Placebo | -6.13 | Standard Error 0.30 | score on a scale | |
| Change From Baseline on the Alzheimer's Disease Cooperative Study - Instrumental Activities of Daily Living (ADCS-iADL) Score (Intermediate (Low-medium) Tau Population) | Donanemab | -2.76 | Standard Error 0.34 | score on a scale | |
| Change From Baseline on the Alzheimer's Disease Cooperative Study - Instrumental Activities of Daily Living (ADCS-iADL) Score (Intermediate (Low-medium) Tau Population) | Placebo | -4.59 | Standard Error 0.32 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04437511/results